J. Goldman & Co’s Medifast MED Stock Holding History

J. Goldman & Co’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-45,000	Closed	-$1.21M	–	270
2013 Q3	$1.21M	Buy	+45,000	New	+$1.2M	0.11%	183

Other funds holding MED

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

GGPE

Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

J. Goldman & Co's MED Position: Q4 2013 in Review

J. Goldman & Co sold out of Medifast (MED) in Q4 2013, closing a stake of 45,000 shares — an estimated $1.21M sold.

J. Goldman & Co first reported a position in MED in Q3 2013 and held it in 1 quarter. The position peaked at $1.21M in Q3 2013. 127 funds tracked by Wall St. Rank hold MED as of Q4 2013.

J. Goldman & Co reported no remaining Medifast position as of Q4 2013 after selling out during the quarter.
J. Goldman & Co sold 45,000 Medifast shares in Q4 2013, an estimated $1.21M.
J. Goldman & Co first reported a position in Medifast in Q3 2013 and held it in 1 quarter.
J. Goldman & Co's Medifast position peaked at $1.21M in Q3 2013.
127 funds tracked by Wall St. Rank held Medifast as of Q4 2013.

Based on J. Goldman & Co's 13F filing for Q4 2013, filed 14 Feb 2014.